Search This Blog

Tuesday, June 24, 2025

Makary reportedly sought CRL for KalVista drug

 Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.


In Focus: US
  • FDA's Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say (Endpoints)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.